Low-Cost, Portable Flexible Nasopharyngoscope in Head & Neck Cancers in Low Resource Settings
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04905134 |
Recruitment Status :
Not yet recruiting
First Posted : May 27, 2021
Last Update Posted : January 25, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Head and Neck Cancer Oral Cancer | Device: Nasopharyngoscope | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 150 participants |
Allocation: | Non-Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Supportive Care |
Official Title: | Partnership to Establish a Practice Based Network to Assess for Head and Neck Cancers Using a Low-Cost Portable Flexible Nasopharyngoscope |
Estimated Study Start Date : | May 2023 |
Estimated Primary Completion Date : | August 2023 |
Estimated Study Completion Date : | August 2023 |

Arm | Intervention/treatment |
---|---|
Active Comparator: Patients evaluated using flexible nasopharyngoscope prototype |
Device: Nasopharyngoscope
Low-cost, flexible scope prototype will compared to rigid scope used as standard of care. |
No Intervention: Patients evaluated using rigid nasopharyngoscope per SOC | |
Active Comparator: Providers using flexible nasopharyngoscope prototype |
Device: Nasopharyngoscope
Low-cost, flexible scope prototype will compared to rigid scope used as standard of care. |
- Number of providers who who reported the FNS is easy to use [ Time Frame: up to 15 minutes ]Measured using a 5 point scale, with 1 = very easy, 2=easier, 3 = same, 4= harder and 5 = very hard
- Rate of image quality of rigid scope [ Time Frame: Day 1 ]Measured using 5 point scale, with 1 being poor and 5 being excellent
- Rate of image quality of flexible scope [ Time Frame: Day 1 ]Measured using 5 point scale, with 1 being poor and 5 being excellent
- Number of patients who reported perceived pain following use of the flexible scope [ Time Frame: Day 1 ]Comparison using a 3 point scale, with 1 being much less and 3 being much more
- Number of patients who experienced an adverse event following the use of the flexible scope [ Time Frame: Day 1 ]measured by a provider questionnaire following completion of flexible scope exam

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Provide signed and dated informed consent form
- Willing to comply with all study procedures and be available for the duration of the study
- Male or female, aged 18 or older
- Patients who clinical meet clinical criteria for rigid scope examination of the upper aerodigestive tract. This includes signs and symptoms such as dysphagia, nasal obstruction, neck mass, throat pain, and hoarseness.
Exclusion Criteria:
- Subjects who have complications from the SOC rigid exam
- Anything that would place the individual at increased risk or preclude the individual's full compliance with or completion of the study.
- Withdrawal of consent during the study duration

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04905134
Contact: Walter Lee, MD | 919-681-8449 | walter.lee@duke.edu | |
Contact: Amy Walker | 919-684-1732 | amy.walker1@duke.edu |
Vietnam | |
National ENT Hospital | |
Hanoi, Vietnam | |
Contact: Trung Nguyen, MD 84 24 3852 3798 trungent23@yahoo.com | |
Principal Investigator: Trung Nguyen, MD |
Principal Investigator: | Walter Lee, MD | Duke Health |
Responsible Party: | Duke University |
ClinicalTrials.gov Identifier: | NCT04905134 |
Other Study ID Numbers: |
Pro00102912 1R01DE028555-01A1 ( U.S. NIH Grant/Contract ) |
First Posted: | May 27, 2021 Key Record Dates |
Last Update Posted: | January 25, 2023 |
Last Verified: | January 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Product Manufactured in and Exported from the U.S.: | No |
Head and Neck Neoplasms Mouth Neoplasms Neoplasms by Site |
Neoplasms Mouth Diseases Stomatognathic Diseases |